Related Experiment Video
Updated: Jun 24, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Experience of a pediatric HIV clinic in Guatemala City
Blanca Samayoa1, Matthew R Anderson, Carlos Grazioso
1Facultad de Ciencias Químicas, Universidad de San Carlos de Guatemala, Guatemala City, Guatemala.
Insights
Pediatric HIV is a significant concern in Guatemala, affecting children across all departments. Prevention of mother-to-child transmission and accessible treatment are crucial public health priorities.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Guatemala faces a growing human immunodeficiency virus (HIV) epidemic.
- Limited literature exists on pediatric HIV in Guatemala.
- This study addresses the gap in understanding pediatric HIV in the region.
Purpose of the Study:
- To describe the clinical experience of a Guatemalan pediatric HIV clinic.
- To analyze pediatric HIV cases and outcomes in Guatemala.
- To inform public health strategies for pediatric HIV/AIDS.
Main Methods:
- Retrospective analysis of clinical data from a Guatemalan pediatric HIV clinic (1997-2006).
- Inclusion of 536 children under 13 years of age.
- Assessment of HIV infection status, exposure, and treatment interventions.
Main Results:
- 536 children registered; 241 HIV-infected, 295 exposed with undetermined status (57 confirmed HIV positive).
- Perinatal exposure was most common; antiretroviral medication and Cesarean section significantly reduced HIV infection risk (OR 0.06).
- 44 deaths occurred in the HIV-infected cohort; no deaths in uninfected children.
Conclusions:
- Pediatric HIV/AIDS is prevalent throughout Guatemala.
- Mother-to-child transmission prevention programs are essential.
- Accessible treatment for families affected by HIV/AIDS must be a public health priority.
Objectives:
To describe the clinical experience of a Guatemalan pediatric HIV clinic and referral center, and fill the gap in literature available on pediatric HIV in Guatemala, a country facing a growing HIV epidemic.
Methods:
Analyses were performed on data available from the clinical databases maintained by the Clínica Familiar Luis Angel García within the Hospital General San Juan de Dios in Guatemala City, Guatemala.
Results:
From January 1997-June 2006, a total of 536 children (individuals under 13 years of age) were registered at the clinic, 54% of them female. At the initial visit, 241 were known to be HIV infected, while 295 were known to have been exposed to HIV, but were of undetermined infection status. Of the 295 with undetermined status, serostatus was determined in 173, and 57 (33%) were HIV positive. The patients came from all 24 departments of Guatemala, but the majority (64%) was from Guatemala City. Most had perinatal exposure; three patients had been sexually exposed to HIV (all male); and the mode of infection could not be determined for six children. In the cohort of children whose infection status was initially undetermined, the provision of antiretroviral (ARV) medication (both pre- and neonatal), in addition to Cesarean section, was associated with an odds ratio of 0.06 for HIV infection (P < 0.001) when compared to children who had no interventions. Highly active antiretroviral therapy (HAART) was administered to 167 HIV-infected children. There were 44 known deaths in this cohort; no deaths occurred among the children who were not infected.
Conclusions:
Pediatric HIV/AIDS is present in all parts of Guatemala. Programs to prevent mother to child transmission and to provide appropriate treatment to families living with HIV/AIDS must be a public health priority.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Genital Herpes
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

